Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit

ConclusionILC patients could derive significant DFS and OS benefits from CT, especially for high-risk patients.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research